ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 699168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 699168; 2) Community: the network communities that were significantly associated with the response to NSC 699168; 3) Molecule: the relationships between components within communities and NSC 699168; 4) MDR: the compounds that were significantly associated with the NSC 699168.

NSC Compound Enrichment Correlation
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0238174255956147 0.50204978
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0238174255956147 0.45077291
NSC 371777 Null 0.0238174255956147 0.39425024
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0238174255956147 0.43929143
NSC 55236 Null 0.0238174255956147 0.1981262
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0238174255956147 0.40557207
NSC 606497 Camptothecin Derivative 0.0238174255956147 0.21641999
NSC 629229 Null 0.0238174255956147 0.1597526
NSC 63878 Cytarabine Hydrochloride AZ 0.0238174255956147 0.29138414
NSC 642324 Null 0.0238174255956147 0.25825063
Total:137  Current:71    [First] [Prev] [Next] [Last]